Evidence map›Paper›PMID 32973538›Full record

ReviewFrontiers in pharmacology2020

Molecular Mechanisms of Action of Emodin: As an Anti-Cardiovascular Disease Drug.

Qianqian Li, Jian Gao, Xiaohan Pang, Aiping Chen, Yi Wang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
10.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Emodin Improves Juvenile Largemouth Bass (Animals : an open access journal from MDPI · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Foods (Basel, Switzerland) · 2024
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Qianqian LiSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Jian GaoSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Xiaohan PangSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Aiping ChenSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Yi WangCollege of Pharmaceutical Sciences, Pharmaceutical Informatics Institute, Zhejiang University, Hangzhou, China.
Beijing University of Chinese Medicine · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emodin is a natural occurring anthraquinone derivative isolated from roots and barks of numerous plants, molds, and lichens. It is found to be an active ingredient in different Chinese herbs including

Indexed as

anti-cardiovascular diseaseemodinmechanisms of actionpolyvalent moleculetargets identification

Identifiers

PMID32973538
PMCPMC7481471
OpenAlexW3082047362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.